Authors: Pan, LC Carpino, PA Lefker, BA Ragan, JA Toler, SM Pettersen, JC Nettleton, DO Ng, O Pirie, CM Chidsey-Frink, K Lu, BH Nickerson, DF Tess, DA Mullins, MA MacLean, DB DaSilva-Jardine, PA Thompson, DD

Citation: Lc. Pan et al., Preclinical pharmacology of CP-424,391, an orally active pyrazolidinone-piperidine growth hormone secretagogue (vol 14, pg 121, 2001), ENDOCRINE, 14(3), 2001, pp. 437-437

Authors: Ke, HZ Qi, H Chidsey-Frink, KL Crawford, DT Thompson, DD

Citation: Hz. Ke et al., Lasofoxifene (CP-336,156) protects against the age-related changes in bonemass, bone strength, and total serum cholesterol in intact aged male rats, J BONE MIN, 16(4), 2001, pp. 765-773

Authors: Shaddy, RE Lambert, LM Fuller, TC Profaizer, T Thompson, DD Baker, SI Osborne, KA Hawkins, JA

Citation: Re. Shaddy et al., Prospective randomized trial of azathioprine in cryopreserved valved allografts in children, ANN THORAC, 71(1), 2001, pp. 43-47

Authors: Ke, HZ Qi, H Crawford, DT Chidsey-Frink, KL Simmons, HA Thompson, DD

Citation: Hz. Ke et al., Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat, ENDOCRINOL, 141(4), 2000, pp. 1338-1344

Authors: Ke, HZ Crawford, DT Qi, H Pirie, CM Simmons, HA Chidsey-Frink, KL Chen, HK Jee, WSS Thompson, DD

Citation: Hz. Ke et al., Droloxifene does not blunt bone anabolic effects of prostaglandin E-2, butmaintains prostaglandin E-2-restored bone in aged, ovariectomized rats, BONE, 24(1), 1999, pp. 41-47

Authors: Schibler, KR Osborne, KA Leung, LY Le, TV Baker, SI Thompson, DD

Citation: Kr. Schibler et al., Recombinant human granulocyte colony-stimulating factor therapy for sepsisin infants with neutropenia - Reply, PEDIATRICS, 103(6), 1999, pp. 1310-1311